The European Society for Radiotherapy and Oncology (ESTRO) and the ESTRO Cancer Foundation (ECF) announce the launch of a new research initiative to explore challenges to the uptake of radiotherapy for lung cancer patients in Europe.

Supported by a grant from AstraZeneca, this project will use qualitative and quantitative research to characterize the radiotherapy access landscape in Europe and develop policy recommendations to improve patient outcomes by closing gaps in access to high-quality radiotherapy. Read more...